Rapid Communication
Copyright ©2008 The WJG Press and Baishideng.
World J Gastroenterol. Apr 7, 2008; 14(13): 2094-2099
Published online Apr 7, 2008. doi: 10.3748/wjg.14.2094
Table 1 Effect of MZAPE on tumor weight, tumor-inhibiting rate, suppression of anti-HEL IgG antibody production, and proliferative responses of PBMC to HEL (n = 20, mean ± SE)
GroupsTumor weight (g)Tumor-inhibiting rate (%)Anti-HEL IgG antibody (A405)Proliferation (× 1000 cpm)
Control4.27 ± 0.600.17 ± 0.026.0 ± 0.7
Simple irradiation1.58 ± 0.40b63.08 ± 6.430.09 ± 0.01b5.31 ± 0.8d
Radiation plus MZAPE1.29 ± 0.33b69.86 ± 7.120.34 ± 0.01b27.4 ± 2.8b
MZAPE2.76 ± 0.37b35.30 ± 7.670.44 ± 0.04b49.6 ± 3.1b